Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
J Comp Neurol ; 510(5): 550-9, 2008 Oct 10.
Article in English | MEDLINE | ID: mdl-18683220

ABSTRACT

Previous studies have demonstrated that ribbon synapses in the retina do not contain the t-SNARE (target-soluble N-ethylmaleimide-sensitive factor attachment protein receptor) syntaxin 1A that is found in conventional synapses of the nervous system. In contrast, ribbon synapses of the retina contain the related isoform syntaxin 3. In addition to its localization in ribbon synapses, syntaxin 3 is also found in nonneuronal cells, where it has been implicated in the trafficking of transport vesicles to the apical plasma membrane of polarized cells. The syntaxin 3 gene codes for four different splice forms, syntaxins 3A, 3B, 3C, and 3D. We demonstrate here by using analysis of EST databases, RT-PCR, in situ hybridization, and Northern blot analysis that cells in the mouse retina express only syntaxin 3B. In contrast, nonneuronal tissues, such as kidney, express only syntaxin 3A. The two major syntaxin isoforms (3A and 3B) have an identical N-terminal domain but differ in the C-terminal half of the SNARE domain and the C-terminal transmembrane domain. These two domains are thought to be directly involved in synaptic vesicle fusion. The interaction of syntaxin 1A and syntaxin 3B with other synaptic proteins was examined. We found that both proteins bind Munc18/N-sec1 with similar affinity. In contrast, syntaxin 3B had a much lower binding affinity for the t-SNARE SNAP25 compared with syntaxin 1A. By using an in vitro fusion assay, we could demonstrate that vesicles containing syntaxin 3B and SNAP25 could fuse with vesicles containing synaptobrevin2/VAMP2, demonstrating that syntaxin 3B can function as a t-SNARE.


Subject(s)
Protein Isoforms/metabolism , Qa-SNARE Proteins/metabolism , Retina/metabolism , SNARE Proteins/metabolism , Synapses/metabolism , Alternative Splicing , Amino Acid Sequence , Animals , Liposomes/metabolism , Membrane Fusion/physiology , Mice , Mice, Inbred C57BL , Molecular Sequence Data , Protein Isoforms/genetics , Qa-SNARE Proteins/genetics , Retina/ultrastructure , SNARE Proteins/genetics , Sequence Alignment , Sequence Homology, Amino Acid , Synapses/ultrastructure , Synaptosomal-Associated Protein 25/genetics , Synaptosomal-Associated Protein 25/metabolism , Tissue Distribution
2.
Cancer Immunol Immunother ; 56(2): 205-15, 2007 Feb.
Article in English | MEDLINE | ID: mdl-16710719

ABSTRACT

The melanoma differentiation-associated gene-7 (mda-7/IL-24) is a unique member of the interleukin 10 (IL-10) family of cytokines, with ubiquitous tumor cell pro-apoptotic activity. Recent data have shown that IL-24 is secreted as a glycosylated protein and functions as a pro-Th1 cytokine and as a potent anti-angiogenic molecule. In this study, we analyzed the activity of Ad-mda7 and its protein product, secreted IL-24, against human breast cancer cells. We show that Ad-mda7 transduction of human breast cancer cells results in G(2)/M phase cell cycle arrest and apoptotic cell death, which correlates with secretion of IL-24 protein. Neutralizing antibody against IL-24 significantly inhibited Ad-mda7 cytotoxicity. IL-24 and IL-10 both engage their cognate receptors on breast cancer cells resulting in phosphorylation and activation of STAT3, however, IL-10 receptor binding failed to induce cell killing, indicating that tumor cell killing by IL-24 is independent of STAT3 phosphorylation. Treatment with exogenous IL-24 induced apoptosis in breast cancer cells and this effect was abolished by addition of anti-IL-24 antibody or anti-IL-20R1, indicating that bystander cell killing is mediated via IL-24 binding to the IL-20R1/IL-20R2 heterodimeric receptor complex. Co-administration of the related cytokine IL-10 inhibited killing mediated by IL-24 and concomitantly inhibited IL-24 mediated up-regulation of the tumor suppressor proteins, p53 and p27(Kip1). In summary, we have defined a tumor-selective cytotoxic bystander role for secreted IL-24 protein and identified a novel receptor-mediated death pathway in breast cancer cells, wherein the related cytokines IL-24 and IL-10 exhibit antagonistic activity.


Subject(s)
Breast Neoplasms/metabolism , Interleukin-10/metabolism , Interleukins/metabolism , Receptors, Interleukin/metabolism , Apoptosis/immunology , Breast Neoplasms/immunology , Cell Line, Tumor , Cell Proliferation , Female , Flow Cytometry , Fluorescent Antibody Technique , Gene Transfer Techniques , Humans , Interleukin-10/immunology , Interleukins/antagonists & inhibitors , Interleukins/immunology , Receptors, Interleukin/immunology
3.
Nat Struct Mol Biol ; 13(8): 748-50, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16845390

ABSTRACT

Synaptic transmission relies on an exquisitely orchestrated series of protein-protein interactions. Here we show that fusion driven by neuronal SNAREs is inhibited by the regulatory protein complexin. Furthermore, inner-leaflet mixing is strongly impaired relative to total lipid mixing, indicating that inhibition by complexin arrests fusion at hemifusion. When the calcium sensor synaptotagmin is added in the presence of calcium, inhibition by complexin is relieved and full fusion rapidly proceeds.


Subject(s)
Nerve Tissue Proteins/metabolism , Synaptotagmin I/metabolism , Adaptor Proteins, Vesicular Transport , Animals , Calcium/metabolism , Drosophila Proteins/genetics , Drosophila Proteins/metabolism , Escherichia coli/genetics , Immunoprecipitation , Liposomes/metabolism , Membrane Fusion/physiology , Mice , Nerve Tissue Proteins/genetics , SNARE Proteins/genetics , SNARE Proteins/metabolism , Synaptic Transmission , Synaptotagmin I/genetics
SELECTION OF CITATIONS
SEARCH DETAIL